Clarifying meaningful use stage 2 now that CMS has announced its final rule


Dermatologists and other eligible professionals (EPs), eligible hospitals and critical access hospitals (CAHs) can now review the upcoming meaningful use stage 2 requirements, now that the Centers for Medicaid and Medicare Services has announced its "final rule" for attestation of meaningful use (MU) stage 2.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.